Brivekimig

Approval Year

Name

Type

Language

IG single chain VH-VH-VH'-VH''-VH' (1-630) [VH anti-TNFSF4 Vicpac/Homsap (Vicugna pacos IGHV3-3*01 (89.8%) -(IGHD) -IGHJ7*01 (92.3%) K120>Q (116)/Homo sapiens IGHV3-23*04 (82.7%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [9.8.16] (26-34.52-59.98-113)) (1-124)

Preferred Name

English

Brivekimig

Official Name

English

immunoglobulin IG single chain of 5 VH (VH-VH-VH'-VH''-VH') monomer, anti-[Homo sapiens TNFSF4 (TNF superfamily member 4, tumor necrosis factor superfamily member 4, OX40 ligand, OX40L, TAX transcriptionallyactivated glycoprotein 1, TXGP1, gp34, CD252)],

Common Name

English

Immunoglobulin, bispecific, pentavalent, anti-(human CD252 antigen) (human-Camelidea monoclonal 1E07 single-domain VHH fragment) fusion protein with peptide linker (G(GGGS)2) fusion protein with anti-(human CD252 antigen) (human-Camelidea monoclonal 1E07

Common Name

English

brivekimig [INN]

Common Name

English

Code System Code Type Description

INN

13019